Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines

Clinical trial NCT00891176 · COMPLETED

Trial details

NCT number: NCT00891176
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neisseria Meningitidis Haemophilus Influenzae Type b

Start date: 2009-05-14
Primary completion: 2012-11-21
Enrollment: 582

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.